Literature DB >> 30338342

Craving espresso: the dialetics in classifying caffeine as an abuse drug.

Max Kenedy Felix Dos Santos1, Elaine C Gavioli1, Lorena Santa Rosa1, Vanessa de Paula Soares-Rachetti1, Bruno Lobão-Soares2.   

Abstract

Caffeine is the most consumed psychoactive substance in the world; in general, it is not associated to potentially harmful effects. Nevertheless, few studies were performed attempting to investigate the caffeine addiction. The present review was mainly aimed to answer the following question: is caffeine an abuse drug? To adress this point, the effects of caffeine in preclinical and clinical studies were summarized and critically analyzed taking account the abuse disorders described in the Diagnostic and Statistical Manual of Mental Disorders (DSM-V). We concluded that the diagnostic criteria evidenced on DSM-V to intoxication-continued use and abstinence are not well supported by clinical studies. The fact that diagnostic criteria is not widely supported by preclinical or clinical studies may be due specially to a controversy in its exactly mechanism of action: recent literature point to an indirect, rather than direct modulation of dopamine receptors, and auto-limitant consumption due to adverse sensations in high doses. On the other hand, it reports clear withdrawal-related symptoms. Thus, based on a classical action on reward system, caffeine only partially fits its mechanism of action as an abuse drug, especially because previous research does not report a clear effect of dopaminergic activity enhance on nucleus accumbens; despite this, there are reports concerning dopaminergic modulation by caffeine on the striatum. However, based on human and animal research, caffeine withdrawal evokes signals and symptoms, which are relevant enough to include this substance among the drugs of abuse.

Entities:  

Keywords:  Abuse Drug; Adenosine; Caffeine; DSM-V; Substance-related disorders; Withdrawal

Mesh:

Substances:

Year:  2018        PMID: 30338342     DOI: 10.1007/s00210-018-1570-9

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  61 in total

1.  Low-dose caffeine physical dependence in humans.

Authors:  R R Griffiths; S M Evans; S J Heishman; K L Preston; C A Sannerud; B Wolf; P P Woodson
Journal:  J Pharmacol Exp Ther       Date:  1990-12       Impact factor: 4.030

Review 2.  Caffeine Use Disorder: A Comprehensive Review and Research Agenda.

Authors:  Steven E Meredith; Laura M Juliano; John R Hughes; Roland R Griffiths
Journal:  J Caffeine Res       Date:  2013-09

3.  The effects of caffeine ingestion on cortical areas: functional imaging study.

Authors:  Chan-A Park; Chang-Ki Kang; Young-Don Son; Eun-Jung Choi; Sang-Hoon Kim; Seung-Taek Oh; Young-Bo Kim; Chan-Woong Park; Zang-Hee Cho
Journal:  Magn Reson Imaging       Date:  2014-01-06       Impact factor: 2.546

4.  Caffeine withdrawal symptoms.

Authors:  K A Stringer; W A Watson
Journal:  Am J Emerg Med       Date:  1987-09       Impact factor: 2.469

5.  Action of caffeine and theophyllamine on supersensitive dopamine receptors: considerable enhancement of receptor response to treatment with DOPA and dopamine receptor agonists.

Authors:  K Fuxe; U Ungerstedt
Journal:  Med Biol       Date:  1974-02

6.  The linear allometric relationship between total metabolic energy per life span and body mass of mammals.

Authors:  Atanas Todorov Atanasov
Journal:  Biosystems       Date:  2006-08-23       Impact factor: 1.973

Review 7.  Adenosine as a signaling molecule in the retina: biochemical and developmental aspects.

Authors:  Roberto Paes-De-Carvalho
Journal:  An Acad Bras Cienc       Date:  2002-09       Impact factor: 1.753

8.  Acute and adaptive motor responses to caffeine in adolescent and adult rats.

Authors:  Dennis E Rhoads; April L Huggler; Lucas J Rhoads
Journal:  Pharmacol Biochem Behav       Date:  2011-04-12       Impact factor: 3.533

Review 9.  Caffeine protects against disruptions of the blood-brain barrier in animal models of Alzheimer's and Parkinson's diseases.

Authors:  Xuesong Chen; Othman Ghribi; Jonathan D Geiger
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

Review 10.  Caffeine physical dependence: a review of human and laboratory animal studies.

Authors:  R R Griffiths; P P Woodson
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

View more
  1 in total

1.  New Potentiometric Screen-Printed Platforms Modified with Reduced Graphene Oxide and Based on Man-Made Imprinted Receptors for Caffeine Assessment.

Authors:  Hisham S M Abd-Rabboh; Abdel El-Galil E Amr; Abdulrahman A Almehizia; Ahmed M Naglah; Ayman H Kamel
Journal:  Polymers (Basel)       Date:  2022-05-10       Impact factor: 4.967

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.